Effectiveness of Mexiletine for Treating People With Non-Dystrophic Myotonia

计划入组 59 人 · 首次发布于 2009 年 1 月 29 日

Contractile Properties of Hypertrofic Muscles in Patients With Non-Dystrophic Myotonia

计划入组 36 人 · 首次发布于 2021 年 3 月 16 日

Using MRI in Patients With Non-dystrophic Myotonia to Access Muscle Contractility

计划入组 25 人 · 首次发布于 2021 年 3 月 22 日

non-erythropoietic cytokine

Non-anticoagulant Heparin

GIP non-peptide

The Cooper Health System, A New Jersey Non-Profit Corporation

United States

REPLIGEN CORPORATION

United States

EMCURE PHARMACEUTICALS LIMITED

United Arab Emirates

Lupin Secures EMA Approval for Pediatric Expansion of Rare Disease Drug Namuscla in Non-Dystrophic Myotonia

Lamotrigine Shows Promise as Alternative Treatment for Non-Dystrophic Myotonia in Head-to-Head Trial

Myotonia May Amplify Muscle Damage in Myotonic Dystrophy Type 1, New Study Reveals